Recent Updates
Recently added Catalysts
RVP

RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B

Key Takeaway: RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B PREFERRED STOCK SHAREHOLDERS LITTLE ELM, Texas, June 30, 2022 - Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board of Directors has declared dividend

Full Press Release Details

RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS
TO SERIES II AND III CLASS B
PREFERRED STOCK SHAREHOLDERS
LITTLE ELM, Texas, June 30, 2022 - Retractable
Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board of Directors has declared dividends
to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.
Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning April 1, 2022 through June 30, 2022. The
dividends will be paid on July 21, 2022 to shareholders of record as of the close of business on July 11, 2022.
Retractable manufactures and markets VanishPoint
and Patient Safe safety medical products and the EasyPoint needle. The VanishPoint
syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the
needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are
uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint
is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The
EasyPoint needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed
by various specialty and general line distributors.
For more information on Retractable, visit its
Forward-looking statements in this press release
are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current
views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate.
However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from
Factors that could cause or contribute to such
differences include, but are not limited to: the impact of COVID-19 on all facets of logistics and operations, as well as costs, Retractable's
ability to scale up production volumes in response to an increase in demand, potential tariffs, Retractable's ability to maintain liquidity;
Retractable's maintenance of patent protection; Retractable's ability to maintain favorable third party manufacturing and supplier arrangements
and relationships; foreign trade risk; Retractable's ability to access the market; production costs; the impact of larger market players
in providing devices to the safety market; and other risks and uncertainties that are detailed from time to time in Retractable's periodic
reports filed with the U.S. Securities and Exchange Commission.
Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President, Chief Financial Officer, and
Chief Accounting Officer
Last updated: Jun 30, 2022